Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-07-28

FDA Approved: HUMATROPE — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved a supplemental application for HUMATROPE (somatropin) submitted by Eli Lilly and Company, authorizing changes to the existing product under a suppl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HUMATROPE (somatropin)

Snippet

SUPPL AP for HUMATROPE (SOMATROPIN)